{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-008377","form_type":"8-K","ticker":"DMAA","cik":"0002028614","company_name":"Drugs Made In America Acquisition Corp.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.827355+00:00","generated_at":"2026-05-27T05:56:23.846268+00:00","sec_items":["1.01","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Drugs Made In America Acquisition Corp. closes $200M IPO, deposits $201M in trust","bullets":["Closed IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200 million.","Simultaneous private placement of 400,000 units to sponsor for $4 million, bringing total trust to $201 million.","Units trade on Nasdaq under DMAAU; ordinary shares (DMAA) and rights (DMAAR) to trade separately later.","Clear Street acted as sole book-running manager; offering made under effective S-1 registration statement.","Underwriters have 45-day option for up to 3M additional units to cover over-allotments."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-008377","json":"https://secwatch.observer/filing/0001213900-25-008377.json","markdown":"https://secwatch.observer/filing/0001213900-25-008377.md","text":"https://secwatch.observer/filing/0001213900-25-008377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:56:23.846268+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c52686294f50a610e8bb9fb100a34e8cb48a8b56","claim":"Drugs Made In America Acquisition Corp.: Adopted Second Amended and Restated Memorandum and Articles of Association in connection with the IPO (effective 2025-01-07).","evidence_excerpt":"On January 7, 2025, and in connection with the IPO, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-01-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}